Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain
Listen to Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.
Decera Clinical Education Oncology Podcast · Óscar Rodríguez-Faba MD, Félix Guerrero Ramos MD PhD FEBU
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer.
Presenters:
Félix Guerrero Ramos, MD, PhD, FEBU
Teaching Collaborator
Department of Surgery
Medicine School
Universidad Complutense de Madrid
Attending Urologist
Department of Urology
UroOncology Unit
Madrid, Spain
Óscar Rodríguez-Faba, MD
Urologist
Uro-Oncology
Fundació Puigvert
Barcelona, Catalonia, Spain
Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.
Link to full program, including associated downloadable slidesets and on-demand Webcast:
http://bit.ly/3kJC5SL
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.